Bionoid Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	2004 - 2008
Period Ending	May '25 May 27, 2025	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	2004 - 2008
Market Capitalization	6	3	2	2	19	5	Upgrade
Market Cap Growth	-80.85%	45.00%	0.04%	-87.90%	293.85%	-36.15%	Upgrade
Enterprise Value	-	3	2	2	19	5	Upgrade
Last Close Price	0.11	145.00	100.00	137.50	1500.00	500.00	Upgrade
PE Ratio	-	-	21.11	-	-	-	Upgrade
PS Ratio	64.38	36.56	-	-	-	-	Upgrade
PB Ratio	-5.19	-2.95	-2.37	-1.26	-22.06	-3.44	Upgrade
EV/Sales Ratio	-	37.26	-	-	-	-	Upgrade
Debt / Equity Ratio	-0.40	-0.40	-0.15	-0.03	-0.25	-0.15	Upgrade
Asset Turnover	0.62	0.62	-	-	-	-	Upgrade
Quick Ratio	0.03	0.03	0.08	0.00	0.47	0.08	Upgrade
Current Ratio	0.07	0.07	0.14	0.00	0.47	0.08	Upgrade
Return on Assets (ROA)	-164.12%	-164.12%	-336.40%	-447.28%	-269.48%	-419.95%	Upgrade
Earnings Yield	-27.33%	-48.12%	4.74%	-170.23%	-20.34%	-69.98%	Upgrade
FCF Yield	-	-10.60%	-4.03%	-39.52%	-9.00%	-9.96%	Upgrade
Buyback Yield / Dilution	-171.32%	-101.25%	-13.90%	-28.63%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.